Condition
Intracerebral Hematoma
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Withdrawn1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05484245Not ApplicableRecruiting
Sonography-guided Resection of Brain Mass Lesions
NCT05477680Not ApplicableRecruiting
Intraoperative Brain Shift Calculation Study
NCT05158660Not ApplicableUnknownPrimary
Assessment of Intracerebral Hematoma
NCT03414307Not ApplicableWithdrawnPrimary
Stereotactic, Robot-assisted Intracerebral Hemorrhage Clot Evacuation
Showing all 4 trials